| Date |
Author |
Presentation Title
|
Organization |
| 30 November 2011 |
Nina Oparina |
Galaxy: web-based platform for modern human proteomics and protein-coding genes studies |
EIMB RAS |
| 23 November 2011 |
Eugene Kolker |
Data at Work |
Predictive Analytics, Seattle Children’s Hospital, Seattle, WA, USA |
| 23 June 2011 |
M.I. Lerman |
How to treat cancer using combined gene therapy?
|
USA |
| 22 June 2011 |
Andrey Rzhetsky |
Computational approaches to elucidate etiology of complex human disorders
|
University of Chicago, Chicago, IL, USA |
| 8 June 2011 |
Ghermes Chilov |
Docking and scoring: overview of docking programs at the 241st National ACS Meeting. Lead Finder program's experiences
|
The N.D. Zelinsky Institute of Organic Chemistry of Rus. Acad. Med. Sci., MolTech Ltd. |
| 25 May 2011 |
Oleg Khoruzhii |
Application of a polarizable force field to calculations of relative protein-ligand binding affinities
|
|
| 9 February 2010 |
V. Savchenko A. Svetlakov A. Paramonov A. Panin |
Virtualization of IT resources |
VMware HP Russia IBS Platformix
|
| 27 January 2010 |
Adel Golovin |
Integration of chemical information with protein sequences and 3D structures in SQL |
European Bioinformatics Institute (EBI), UK |
| 9 December 2009 |
Igor Baskin |
Property prediction of chemical compounds using fragmental descriptors |
Chemical department of MSU |
| 7 October 2009 |
Timofey Pirkov |
“Platinum” web-service for research of hydrophobic organisation of biomolecular systems |
Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry |
| 29 April 2009 |
Sergey Trepalin |
Complex of program for working with chemical data |
|
| 18 February 2009 |
Oleg Demin |
Application of prostaglandin metabolism kinetic models in endothelial and thrombocyte cells for side effect mechanism identification of nonsteroidal antiinflammatory drug |
Institute of system biology St.P. |
| 28 January 2009 |
Elena Ponomarenko |
Construction of semantic enzymes network based on PubMed reference database |
Institute of biomedical chemistry of RAMS |
| 17 December 2008 |
Evgeniy Radchenko |
Molecular Field Topology Analysis method and virtual screening |
Chemical department of MSU |
| 12 November 2008 |
Gemes Chilov |
New approach for increasing accuracy of prediction of structure and binding constant of enzyme-ligand complex, and virtual screening |
ООО «Molecular technology» |
| 28 October 2008 |
Fazli Ataullahanov |
Virtual erythrocyte and congenital anemia |
Center of Theoretical problems of physical-chemical pharmacology of RAS |
| 15 October 2008 |
Vladimir Sulimov |
New thrombin inhibitors: molecular design and experimental discovery |
Research Computing Center of MSU |
| 4 July 2008 |
Olga Krebs |
Sabio-RK: integrating reaction kinetics data for systems biology |
EML Research, GmbH, Heidelberg, Germany |
| 5 July 2007 |
Dmitriy Kireev |
Chemo-, bioinformatics. Intimate contact of third type. |
«Sanofi-Aventis», France |
| 25 April 2007 |
Sergey Rahmanov |
Empirical interatomic potentials in enzymes |
Scientific Center of Russian Federation Research Institute for Genetics and Selection of Industrial Microorganisms |
| 21 March 2007 |
V Kohov |
Models, methods and programs for analysis of chemical compounds complexity and similarity |
Applied mathematics department of MEI |
| 16 January 2007 |
Dmitry Kazakov |
Computational algorithms for protein-protein interaction prediction and solvent mapping of proteins |
Boston University, USA |
| 20 December 2006 |
Alexander Serbin, Pavel Ivanov |
Viral and antiviral macromolecules |
A.V. Topchiev Institute of Petrochemical Synthesis |
| 12 April 2006 |
Sergey Andreev |
Metabolit predictions and selection of biological active chemical compounds using MetaDrug program |
GeneGo, Inc |
| 1 March 2006 |
Oksana Galzitskaya |
Theoretical research of enzymes and peptides folding |
Institute of protein research Russian Academy of Sciences |
| 7 February 2006 |
Peter Fedichev |
Drug development based on new molecular modelling methods |
Quantum Pharmaceuticals |
| 7 December 2005 |
Oleg Raevskiy |
ADME property optimization of new drug structures |
IPAC RAS |